BRCA1-methylated triple negative breast cancers previously exposed to neoadjuvant chemotherapy form RAD51 foci and respond poorly to olaparib

Authors: Carolina Velazquez, Esin Orhan, Imene Tabet, Lise Fenou, Béatrice Orsetti, José Adélaïde, Arnaud Guille, Simon Thézénas, Evelyne Crapez, Pierre-Emmanuel Colombo, Max Chaffanet, Daniel Birnbaum, Claude Sardet, William Jacot, Charles Theillet

Source: Frontiers in Oncology, Vol 13 (2023)

Subject Terms: TNBC, BRCA1 methylation, RAD51, nuclear foci, HRD (homologous recombination deficiency), Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2023.1125021/full; https://doaj.org/toc/2234-943X

Access URL: https://doaj.org/article/e04a4c983fe14d5c8fffd7f0ddb98082